Enanta Pharmaceuticals, Inc.
ENTA
$8.68
$0.030.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 204.11M | 193.38M | 216.69M | 248.19M | 230.09M |
| Total Receivables | 8.36M | 40.63M | 40.16M | 38.65M | 40.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.24M | 8.86M | 10.68M | 12.41M | 15.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 608.00K | 608.00K | 608.00K |
| Total Current Assets | 222.71M | 242.86M | 268.15M | 299.85M | 286.58M |
|
|
|||||
| Total Current Assets | 222.71M | 242.86M | 268.15M | 299.85M | 286.58M |
| Net Property, Plant & Equipment | 74.87M | 76.68M | 77.04M | 73.35M | 66.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.45M | 3.46M | 3.45M | 3.45M | 3.47M |
| Total Assets | 301.03M | 322.99M | 348.64M | 376.65M | 398.82M |
|
|
|||||
| Total Accounts Payable | 3.55M | 4.76M | 4.73M | 8.00M | 10.68M |
| Total Accrued Expenses | 10.85M | 8.31M | 10.58M | 13.55M | 12.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.15M | 32.88M | 33.75M | 35.99M | 34.73M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 44.55M | 45.95M | 49.05M | 57.54M | 58.23M |
|
|
|||||
| Total Current Liabilities | 44.55M | 45.95M | 49.05M | 57.54M | 58.23M |
| Long-Term Debt | 121.29M | 126.73M | 131.09M | 136.13M | 143.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.66M | 56.54M | 56.45M | 53.94M | 48.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 252.00K | 243.00K | 235.00K | 231.00K | 227.00K |
| Total Liabilities | 221.75M | 229.46M | 236.83M | 247.84M | 249.91M |
|
|
|||||
| Common Stock & APIC | 465.91M | 461.74M | 457.18M | 451.55M | 443.79M |
| Retained Earnings | -386.23M | -367.97M | -345.33M | -323.04M | -294.22M |
| Treasury Stock & Other | -402.00K | -224.00K | -29.00K | 302.00K | -653.00K |
| Total Common Equity | 79.28M | 93.54M | 111.82M | 128.81M | 148.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 79.28M | 93.54M | 111.82M | 128.81M | 148.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 79.28M | 93.54M | 111.82M | 128.81M | 148.92M |
|
|
|||||